Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PETS
PETS logo

PETS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Petmed Express Inc (PETS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.230
1 Day change
-3.46%
52 Week Range
4.320
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Petmed Express Inc (PETS) is not a strong buy at this moment for a beginner investor with a long-term horizon. While there are some positive catalysts such as insider buying and a potential short-term upward trend, the company's weak financial performance, bearish technical indicators, and lack of strong trading signals suggest a cautious approach. Holding or waiting for better entry points would be more prudent.

Technical Analysis

The technical indicators are bearish. The MACD is below zero and negatively contracting, the RSI is neutral at 28.726, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 2.293 and resistance at 2.545.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate a bullish sentiment in the options market, but the overall volume is low, limiting its significance.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
4

Positive Catalysts

  • Insider buying has increased by 174.01% over the last month, indicating confidence from company insiders. Additionally, stocks with similar candlestick patterns show a 100% chance of a 3.14% increase in the next day and a 13.04% increase in the next week.

Neutral/Negative Catalysts

  • The company's financial performance is weak, with a significant YoY revenue drop of -21.75% in Q3 2026 and a negative net income of -$10.55M. Gross margin has also declined by -19.33% YoY. No recent news or congress trading data is available to support a positive narrative.

Financial Performance

In Q3 2026, revenue dropped by -21.75% YoY to $40.66M, while net income increased to -$10.55M, up 1392.64% YoY. EPS improved to -0.5, up 1566.67% YoY, but gross margin declined to 22.58%, down -19.33% YoY. Overall, the financials indicate a struggling business with some minor improvements in profitability metrics.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes are available for PETS.

Wall Street analysts forecast PETS stock price to rise
Analyst Rating
0
Wall Street analysts forecast PETS stock price to rise
Buy
Hold
Sell
0
Current: 2.310
sliders
Low
0
Averages
0
High
0
0
Current: 2.310
sliders
Low
0
Averages
0
High
0
Morgan Stanley
Erin Wright
Sell
Maintains
$3.5 → $3.2
AI Analysis
2025-04-17
Reason
Morgan Stanley
Erin Wright
Price Target
$3.5 → $3.2
AI Analysis
2025-04-17
Maintains
Sell
Reason
Morgan Stanley lowered the firm's price target on PetMed Express to $3.20 from $3.50 and keeps an Underweight rating on the shares. The pet medication market has become increasingly competitive and 49% of veterinarians in the firm's survey suggest PetMed Express is losing incremental share, the analyst tells investors. The firm is tempering its target on a tougher consumer macro environment and competitive headwinds following its proprietary AlphaWise survey of 75 U.S. companion animal veterinarians.

People Also Watch